A Study of the Natural Progression of Interstitial Lung Disease (ILD)

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Chicago
Study ID
NCT00470327
Status
Recruiting
Apply to this trial

Conditions

  • Connective Tissue Disorder
  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Diseases
  • Sarcoidosis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Key Dates

Start date
Sep 30, 2005
Status verified
Jun 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
4,000 participants (estimated)

Primary Outcome Measure

Natural history of course of disease in patients with Interstitial lung disease (ILD) [ Time Frame: Yearly ]

Central Contacts

  • Vanita Patel, MPH
    773-702-1012

Locations (1)

FacilityCityStateZIPSite coordinators
University of ChicagoChicagoIllinois60637
Mary E Strek, MD
[email protected]
773-702-3609
Mary E Strek, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chicago, IL

By research site
University of Chicago· Chicago, IL

Related Studies